CDH1 and lung carcinoma: Aberrant hypermethylation phenotype of tumor suppressor genes by DNMT3a activity has been reversed by expression of miR-101-3p in a model of lung cancer, where DNMT3 repression led to promoter hypomethylation and re-expression of tumor suppressor CDH1 [67].